Trade Summary

5 days ago, Van Tuyl Christopher, serving as Chief Legal Officer at Immunovant, Inc. (IMVT), sold 2,634 shares at $35.39 per share, for a total transaction value of $93,217.26. Following this transaction, Van Tuyl Christopher now holds 180,597 shares of IMVT.

This sale represents a 1.44% decrease in Van Tuyl Christopher's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 18, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 4:02 PM ET, 4 days after the trade was made.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.